JZP-110
Phase 3Completed 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Narcolepsy
Conditions
Narcolepsy, Obstructive Sleep Apnea
Trial Timeline
May 1, 2015 → Dec 1, 2017
NCT ID
NCT02348632About JZP-110
JZP-110 is a phase 3 stage product being developed by Jazz Pharmaceuticals for Narcolepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT02348632. Target conditions include Narcolepsy, Obstructive Sleep Apnea.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03037203 | Phase 2 | Completed |
| NCT02348619 | Phase 3 | Completed |
| NCT02348632 | Phase 3 | Completed |
Competing Products
20 competing products in Narcolepsy